Septerna: Funding, Investors & Team (Oct 2026)
Septerna is a biotech firm focused on finding and developing groundbreaking small-molecule drugs that specifically target G protein-coupled receptors. By integrating cutting-edge small molecule drug discovery techniques with GPCR drug targets, Septerna aims to enhance patient well-being. Their Native Complex platform serves as the driving force behind these endeavors.
Septerna has raised $150M across 1 funding round on record, the most recent a Series B of $150M announced in Jul 2023.
That round is above the $8.4M median round size for Biotechnology companies tracked on FundedIQ over the last two years.
Septerna Company Profile and Key Stats
Latest funding round on record: Jul 2023.
Septerna Funding Rounds
Septerna Founders and Leadership Team
No contact details are on record for this team yet.
Septerna Funding Compared to Other Biotechnology Startups
Septerna's latest round of $150M is above the median round in Biotechnology. Medians cover the last 24 months of disclosed rounds.
Funded Startups Like Septerna in Biotechnology and San Francisco
Companies Similar to Septerna
Prolific Machines is a biotech company located in San Francisco, California, that was established in 2020. It…
Altay Therapeutics is a biotech company focused on finding and discovering small molecule therapies for…
Kallyope, we believe that the gut is the gateway to our internal world. Containing millions of neurons, the…
Astrocyte Pharmaceuticals is a drug development company that helps in the recovery and well-being of brain…
Tiny Health offers a gut health test specifically designed for mothers and babies aged 0 to 3 years.…
Junevity is dedicated to using cutting-edge transcription factor medicines to combat age-related diseases.…
Arkea Bio creates technology aimed at reducing greenhouse gas (GHG) emissions in the agricultural sector.
Serán is a contract development and manufacturing organization providing a comprehensive suite of…
Precision’s goal is to provide breakthrough treatments for the one billion patients worldwide suffering from…
Enveda is a biotechnology company that utilizes AI-powered tools to explore and characterize molecules from…
Avery Therapeutics, Inc. is a company dedicated to developing tissue engineered therapeutics to treat…
Septerna Funding FAQs
What does Septerna do?
Septerna is a biotech firm focused on finding and developing groundbreaking small-molecule drugs that specifically target G protein-coupled receptors. By integrating cutting-edge small molecule drug discovery techniques with GPCR drug targets, Septerna aims to enhance patient well-being. Their Native Complex platform serves as the driving force behind these endeavors.
How much funding has Septerna raised?
Septerna has raised $150M across 1 round on record. The most recent is a Series B of $150M announced in Jul 2023.
When did Septerna last raise funding?
Septerna's most recent funding round on record is a Series B of $150M, announced in Jul 2023.
Who founded Septerna?
FundedIQ lists Arthur Christopoulos (Founder) at Septerna.
Where is Septerna headquartered?
Septerna is based in San Francisco, California, United States.
How many employees does Septerna have?
Septerna is in the 51-100 employee band.
How does Septerna's funding compare to other Biotechnology startups?
Septerna's latest round of $150M is above the $8.4M median round size for Biotechnology companies on FundedIQ across 4,185 tracked companies over the last two years.
About FundedIQ's Septerna Funding Data
FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.
Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for Septerna is left off this page rather than filled in.
Know who just raised. Then know who to reach.
Startup funding intelligence on every funded startup: the round, the investors and the founders, as a file in your inbox or searchable in the app.
Radar from $49/mo · Pro from $149/mo. Card required, nothing charged until day 15, and we email you 3 days before that. Need something specific? Custom plans from $499/mo.